openPR Logo

Press Releases from ORGENTEC Diagnostika (11 total)

Fully Automated Chlamydia Diagnostics from ORGENTEC

Mainz, June 19, 2012 – ORGENTEC Diagnostika (www.orgentec.com) has introduced six new tests for the diagnosis of infectious diseases. The new ELISA tests detect antibodies against Chlamydia trachomatis and Chlamydia pneumoniae. In addition, these test systems make it possible to differentiate between acute, latent, and chronic infection with these widespread bacterial pathogens. The new tests for the serological diagnosis of Chlamydia were developed specifically for Alegria®, ORGENTEC Diagnostika’s random access analyser.

Online Immunofluorescence Guide for Diagnosis of Autoimmune Diseases

Mainz, May 09 2012 – From now on the Immunofluorescence Guide for the Modern Autoimmunity Laboratory is available as a free ebook. The online reference work with numerous pictures of immunofluorescence patterns is accessible from the ORGENTEC Diagnostika website (www.orgentec.com) and from the website of the GRÜNE CLUB AUTOIMMUN (www.der-gruene-club.at). The online guide is public domain without login or registration. Whether it is the immunofluorescence pattern of antinuclear antibodies (ANA) on

Autoantibody Diagnostics in Autoimmune Liver Diseases

ORGENTEC Diagnostika (www.orgentec.com) has developed four new laboratory tests for the diagnosis of autoimmune liver diseases. These tests are now on the market. They are based on ELISA technology and were specifically developed for fully automated analysis with Alegria®. The new tests systems, called Anti-Sp100, Anti-gp210, Anti-LKM-1, and Anti-SLA, reliably detect specific autoantibodies that are characteristic of various autoimmune liver diseases. The tests thus also allow for reliable differentiation between these

A New Healthcare App: ORGENTEC Autoimmunity Guide

The ORGENTEC Autoimmunity Guide is now available for download from the Apple iTunes App Store and the Android Market. This app from Mainz-based ORGENTEC Diagnostika GmbH (www.orgentec.com) makes it possible to call up information about autoimmune diseases easily and comfortably from a smartphone or tablet – precisely, compactly, and without extensive searching. The ORGENTEC app offers comprehensive information about the diagnosis and monitoring of autoimmune diseases by means of antibody detection.

Autoimmune Disease Diagnostics: High Sensitivity ACPA Test for Rheumatoid Arthri …

Mainz, November 16, 2011 – For Medica 2011, ORGENTEC Diagnostika presents a new laboratory test for the diagnosis of rheumatism. The highly sensitive Anti-CCP hs (high sensitive)® test makes possible the early diagnosis of rheumatoid arthritis (RA), which in turn allows for successful treatment of this autoimmune disease. The new Anti-CCP hs (high sensitive)® test is the most recent development in the area of ACPA testing. This innovate enzyme immunoassay combines

Liver Disease Diagnostics by Immunoblot Test System

Mainz based ORGENTEC Diagnostika GmbH has developed a new immunoblot test for the serological diagnosis of autoimmune liver disease. Liver-9-Line facilitates the rapid and cost-effective diagnosis of autoimmune hepatitis (type 1 and type 2 AIH) and primary biliary cirrhosis (PBC) in a single step. The test system also allows for the reliable differentiation of these autoimmune diseases from other diseases of the liver. This immunoblot is suitable for initial and differential

Coface Arena: Back Straight Becomes ORGENTEC Stands

The Mainz-based company ORGENTEC Diagnostika has extended its involvement with 1. FSV Mainz 05 and will continue to sponsor stands at the new Coface Arena in Mainz. As they did in the Bruchweg Stadium, the globally active company, which specializes in laboratory tests, will keep the naming rights for the back straight in the new stadium built for FSV Mainz 05 for three years. In addition, ORGENTEC Diagnostika will have a

ORGENTEC Automates Infection Disease Diagnostics: ELISA Test Systems for Infecti …

Mainz, 14/12/2010 – ORGENTEC Diagnostika has successfully entered the field of infectious disease diagnostics. The first ELISA test systems for Alegria® were presented at Medica 2010, the first test kits will be delivered in early 2011. The ORGENTEC serological tests for infectious diseases were developed specifically for Alegria®, ORGENTEC Diagnostika’s random-access analyser. The new test systems can be used to rapidly, automatically, and economically test individual patient samples for specific pathogens,

iVISION Scanware: Automated Evaluation of Immunoblots

Mainz, 06/12/2010 – With the introduction of iVISION Scanware, ORGENTEC Diagnostika has made it possible to automate the evaluation of immunoblots. The software allows these effective and robust test systems to be objectively assessed and the laboratory test results efficiently stored and archived. By graphically representing test results, the software very effectively aids physicians and laboratory personnel in interpreting results and makes it possible to obtain a diagnosis within a few

Celiac Disease: ORGENTEC Diagnostika Launches New Blood Tests

Mainz, 09. July 2010 – ORGENTEC Diagnostika (orgentec.com), developer of blood test systems, has launched three new diagnostic tests for diagnosing celiac disease. This new test line completes ORGENTEC’s product portfolio for accurate diagnosis of gastrointestinal disorders. Celiac disease is an (auto)immunologically mediated intestinal intolerance to proteins (gluten) from wheat and other cereals in genetically predisposed children and adults. Despite initial estimates, celiac disease is more common than previously assumed. Besides

Rapid Detection of Rheumatoid Arthritis / Early diagnosis is critical for treatm …

Mainz, Germany – Rheumatoid arthritis, the most common chronic inflammatory disease of the joints, can now be more quickly and reliably detected. This is made possible by a rapid test that can be used to check patients’ blood for antibodies against mutated citrullinated vimentin (Anti-MCV). If inflammation of the joints is present and MCV antibodies are found in the blood, it is very highly probable that rheumatoid arthritis is at the